RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Why paying off EMD Sorono ?palinc2000 wrote: I think it is fair to assume that the prepayment was done with an ulterior motive in mind.
Maybe Jay Jay has a point ....... Maybe its a valuation tool !
For what purpose? Buyout or merger not necessarily.
Maybe the goal is a Nasdaq Listing and a US Offering in a not too distant future.I predict that Th will publish financial statements in US dollars rather than in Canadian $ starting Dec 2018.
Exactly! Thera management seems to beef up Thera balance sheet in preparation for something related to the valuation of the company..
I dont think Nasdaq listing requirements would have anything to do with EBITDA. Without this move, Thera is already qualified for Nasdaq listing (see below):
Link: https://venturelawcorp.com/listing-requirements-nasdaq/
A US secondary offering doesn't seems to be realistic without a Nasdaq listing. So, it is even less likely than Nasdaq listing.
We are left with the possibility of a buyout or merger. I 've seen this scenario before and last time I have been through was an all-cash buyout at $31/share from current SP of $13.
I think it would be a fair offer. Opinion ?